Skip to main content
. 2019 Sep 16;2019(9):CD012643. doi: 10.1002/14651858.CD012643.pub2
Notes Title: Bulky disease does not adversely affect overall survival in early stage Hodgkin lymphoma: Role of interim PET and possible omission of radiotherapy in select patients.
(Conference abstract)
Aim
  • To assess the impact of disease bulk, interim PET and treatment modality on outcomes


Study design
  • Retrospective, 1995 to 2011


Country/treatment centre(s)
  • USA (Cleveland Clinic, Cleveland OH)


Number of included participants
  • 121


Inclusion criteria
  • Previously untreated HL, early stages (I and II)


Exclusion criteria
  • Missing clinical data


Treatment
  • ABVD or other chemotherapy (not specified)


Primary outcome measure(s)
  • Overall survival

  • Progression‐free survival